ASK

Inhibitory Selectivity

ASK Products

Catalog No. Information Product Use Citations Product Validations
S8289

NQDI-1

NQDI 1, an inhibitor of ASK1(apoptosis signal-regulating kinase 1), attenuates acute ischemic renal injury by modulating oxidative stress and cell death.
Int J Cancer, 2019, 10.1002/ijc.32615
J Neuroinflammation, 2019, 16(1):83
J Steroid Biochem Mol Biol, 2019, 187:166-173
S8292

Selonsertib (GS-4997)

GS-4997 is a highly selective and potent once-daily oral ASK1 inhibitor with potential anti-inflammatory, antineoplastic and anti-fibrotic activities.
Cell Signal, 2020, 68:109528
Arterioscler Thromb Vasc Biol, 2019, 39(12):e253-e272
Oncol Res, 2019, 27(8):945-956
Catalog No. Information Product Use Citations Product Validations
S8289

NQDI-1

NQDI 1, an inhibitor of ASK1(apoptosis signal-regulating kinase 1), attenuates acute ischemic renal injury by modulating oxidative stress and cell death.
Int J Cancer, 2019, 10.1002/ijc.32615
J Neuroinflammation, 2019, 16(1):83
J Steroid Biochem Mol Biol, 2019, 187:166-173
S8292

Selonsertib (GS-4997)

GS-4997 is a highly selective and potent once-daily oral ASK1 inhibitor with potential anti-inflammatory, antineoplastic and anti-fibrotic activities.
Cell Signal, 2020, 68:109528
Arterioscler Thromb Vasc Biol, 2019, 39(12):e253-e272
Oncol Res, 2019, 27(8):945-956
Tags: ASK inhibition | ASK cancer | ASK activation | ASK target | ASK tumor | ASK phosphorylation | ASK activity | ASK inhibitor drugs | ASK kinase assay | ASK inhibitor cancer | ASK inhibitor therapy | ASK signaling pathway | ASK inhibitor review